Matinas BioPharma: Q4 Earnings Insights

Matinas BioPharma Hldgs MTNB reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:15 AM.

Here's what investors need to know about the announcement.

Earnings

Matinas BioPharma Hldgs reported in-line EPS of $-0.03 versus an estimate of $-0.03.

Revenue was down $62.50 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 1.29% drop in the share price the next day.

Here's a look at Matinas BioPharma Hldgs's past performance:

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.